Saroja Pharma IPO GMP, Review, Price, Allotment

Last updated on September 13, 2023

Saroja Pharma IPO description – Saroja Pharma Industries was founded in 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, with a vision of becoming a globally integrated and highly regarded pharmaceutical and healthcare company. Saroja Pharma trades in Pharma API, Pharma Intermediates, Chemicals, and Solvents used for pharmaceutical products, and human and veterinary medicine. The Company was formed with a mission being providing clientele with specification-based approved products at a competitive pricing with hassle-free dispatch within India or aboard contributing to cost effectiveness in end products for human and veterinary medicine.

The product demand by its clientele is manufactured as per their specifications by suppliers initially in sample size thereafter on client testing and approval the order is finalized. The approved specified product is manufactured for the order quantity to be dispatched by the appropriate mode of transport within India or abroad. Growth in recent years has propelled the company to venture into the manufacturing of API Pharma products, for veterinary use.

As of 31 March 2023, the company had a total of 13 employees, all working at its corporate office.

Promoters of Saroja Pharma – Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble

---

Saroja Pharma IPO Details

Saroja Pharma IPO Dates	31 Aug – 5 Sep 2023
Saroja Pharma Issue Price	INR 84 per share
Fresh issue	10,84,800 shares (INR 9.11 crore)
Offer For Sale	NIL
Total IPO size	10,84,800 shares (INR 9.11 crore)
Minimum bid (lot size)	1,600 shares (INR 134,400)
Face Value	INR 10 per share
Retail Allocation	50%
Listing On	NSE SME

---

Saroja Pharma Financial Performance

	FY 2021	FY 2022	FY 2023
Revenue	36.66	55.63	50.19
Expenses	35.71	54.38	48.86
Net income	0.73	1.14	1.06

---

Saroja Pharma Offer News

• Saroja Pharma Industries India RHP
• Saroja Pharma Industries India Draft Prospectus
• ASBA IPO Forms
• Live IPO Subscription Status
• IPO Allotment Status

---

Saroja Pharma Valuations & Margins

	FY 2021	FY 2022	FY 2023
EPS	2.69	3.96	3.61
PE ratio	–	–	23.27
RONW (%)	78.14	28.32	20.85
NAV	3.44	14.00	17.33
ROCE (%)	26.0	25.0	25.0
EBITDA (%)	3.78	4.36	5.73
Debt/Equity	3.22	1.52	2.00

---

Saroja Pharma IPO GMP Today

Date	Consolidated IPO GMP	Kostak	Subject to Sauda
Coming soon	–	–	–

---

Saroja Pharma IPO Subscription – Live Updates

Category	NII	Retail	Total
Shares Offered	569,600	515,200	1,084,000
5 Sep 2023	2.72	14.74	8.44
4 Sep 2023	1.11	7.44	4.12
1 Sep 2023	0.52	3.65	2.00
31 Aug 2023	0.09	1.52	0.77

---

Saroja Pharma Offer Lead Manager

SWASTIKA INVESTMART LIMITED
Flat No18 Floor 2 North Wing, Madhaveshwar
Coop Hsg Society Ltd Madhav Nagar,
11/12 S V Road Andheri W Mumbai Mumbai City – 400058
Phone: +91-22-26254568-69
Email: [email protected]
Website: www.swastika.co.in

---

Saroja Pharma Offer Registrar

KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com

---

Saroja Pharma Contact Details

SAROJA PHARMA INDUSTRIES INDIA LIMITED
Shop No. 209, 2nd Floor, Ecstacy, City of Joy,
Jata Shankar Dosa Marg, Mulund West Mumbai (MH) – 400080
Phone: +91 (022) 2081 0011
E-mail: [email protected]
Website: www.sarojapharma.com

---

Saroja Pharma IPO Allotment Status

Saroja Pharma IPO allotment status is now available on the KFin Tech website. Click on this link to get allotment status.

---

Saroja Pharma IPO Dates & Listing Performance

IPO Opening Date	31 August 2023
IPO Closing Date	5 September 2023
Finalization of Basis of Allotment	8 September 2023
Initiation of refunds	11 September 2023
Transfer of shares to demat accounts	12 September 2023
IPO Listing Date	13 September 2023
Opening Price on NSE SME	INR 65 per share (down 22.62%)
Closing Price on NSE SME	INR 68.25 per share (down 18.75%)

---

IPO FAQs